Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cote

Showing results (621-630 of 630) with videos related to

Pageof 63
Sort By:
You have reached the last page of results.This site can display upto 630 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent GlioblastomaLakshmi Nayak, Annette M Molinaro, Katherine Peters, et al.
Archives of Pathology & Laboratory Medicine|June 25, 2009
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancerAntonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancerAntonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, et al.
Archives of Neurology|December 17, 2009
Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson diseaseRoy N Alcalay, Helen Mejia-Santana, Ming Xin Tang, et al.
Journal of Clinical and Experimental Neuropsychology|February 26, 2010
Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's diseaseRoy N Alcalay, Helen Mejia-Santana, Ming X Tang, et al.
Journal of the International Neuropsychological Society : JINS|November 25, 2010
Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD StudyElise Caccappolo, Roy N Alcalay, Helen Mejia-Santana, et al.
Archives of Neurology|June 19, 2010
Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease studyKaren S Marder, Ming X Tang, Helen Mejia-Santana, et al.
JAMA Neurology|November 6, 2013
Cognitive and motor function in long-duration PARKIN-associated Parkinson diseaseRoy N Alcalay, Elise Caccappolo, Helen Mejia-Santana, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 22, 2014
Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancerMahul B Amin, Steven C Smith, Victor E Reuter, et al.
Cell Reports. Medicine|September 16, 2023
The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoringSyeda Maheen Batool, Anudeep Yekula, Prerna Khanna, et al.
Pageof 63

Showing results (621-630 of 630) with videos related to

Sort By:
Pageof 63
You have reached the last page of results.This site can display upto 630 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent GlioblastomaLakshmi Nayak, Annette M Molinaro, Katherine Peters, et al.
Archives of Pathology & Laboratory Medicine|June 25, 2009
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancerAntonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancerAntonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, et al.
Archives of Neurology|December 17, 2009
Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson diseaseRoy N Alcalay, Helen Mejia-Santana, Ming Xin Tang, et al.
Journal of Clinical and Experimental Neuropsychology|February 26, 2010
Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's diseaseRoy N Alcalay, Helen Mejia-Santana, Ming X Tang, et al.
Journal of the International Neuropsychological Society : JINS|November 25, 2010
Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD StudyElise Caccappolo, Roy N Alcalay, Helen Mejia-Santana, et al.
Archives of Neurology|June 19, 2010
Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease studyKaren S Marder, Ming X Tang, Helen Mejia-Santana, et al.
JAMA Neurology|November 6, 2013
Cognitive and motor function in long-duration PARKIN-associated Parkinson diseaseRoy N Alcalay, Elise Caccappolo, Helen Mejia-Santana, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 22, 2014
Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancerMahul B Amin, Steven C Smith, Victor E Reuter, et al.
Cell Reports. Medicine|September 16, 2023
The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoringSyeda Maheen Batool, Anudeep Yekula, Prerna Khanna, et al.
Pageof 63